DHCNL Stock Analysis

Diversified Healthcare Trust

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend BUY TREND
Bullish
The available trend signal is constructive.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio -267.29
Not Meaningful
Negative or missing earnings make P/E hard to use.
P/E shows how much investors pay for each dollar of earnings.
ROIC -7.00%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Interest Coverage -0.19x
Poor
Negative coverage means earnings are not covering interest costs.
Interest coverage shows how easily earnings cover interest costs.
Price $18.71
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
💰 Dividend Income Dividend Payer
$0.39 quarterly

Annualized: $1.56 • Yield: 8.35%

Last ex-dividend: 2026-08-14. Dividend payments can change or be suspended.
Estimated income from $1,000 invested $20.88 per quarterly payment $83.51 estimated yearly Based on cached price. Estimates exclude taxes, dividend changes, and fractional-share limitations.
Last updated: 2026-07-07 08:24:09

Performance Overview

Trailing adjusted-close returns as of 2026-07-02. Benchmark is SPY.

YTD Return

DHCNL +10.41%
SPY +9.80%

1-Year Return

DHCNL +19.03%
SPY +21.37%

3-Year Return

DHCNL +63.76%
SPY +74.40%

5-Year Return

DHCNL +10.94%
SPY +83.76%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Investment Research & Analysis

Plain-English investment research explaining financial strengths, weaknesses, valuation, and risks. Educational information, not personalized financial advice.

Research generated: October 22, 2026 at 7:04 PM EDT

Diversified Healthcare Trust (DHCNL) is currently presenting a complex profile characterized by significant operational headwinds and negative profitability metrics. As of the latest available data, the company is navigating a period of financial distress, evidenced by negative earnings per share and an inability to cover interest obligations from its current operating results. While the stock carries a "BUY TREND" signal according to certain moving average indicators, the underlying fundamental health of the business remains deeply concerning for long-term investors.

StockValueFinder Assessment:
The primary StockValueFinder grade for DHCNL is 18.27 out of 100, which falls under the label "Insufficient Data." This low score reflects a fundamental lack of positive financial momentum across several key categories. While the market strength component shows a relatively higher score of 67.44, this appears disconnected from the core business quality and earnings growth metrics. The company’s earnings growth score is notably low at 10, and the overall rating is designated as AVOID. This assessment suggests that while market sentiment or technical trends might occasionally flicker, the structural integrity of the company's earnings engine is currently failing to meet basic investment standards.

Earnings and Profitability:
The profitability profile of Diversified Healthcare Trust is currently negative, which presents a significant hurdle for any value-oriented investor. The company reports an Earnings Per Share (EPS) of -0.07, meaning it is losing money on a per-share basis rather than generating profit for its shareholders. Furthermore, the Return on Invested Capital (ROIC) is -7.001%. ROIC is a critical metric that measures how effectively a company turns the capital it uses into profit; a negative value here indicates that the company is actually eroding its capital base through its operations. When a firm cannot generate positive returns on the money it invests, the long-term sustainability of its business model becomes a primary concern.

Capital Efficiency and Financial Strength:
Financial risk is a prominent theme in the analysis of DHCNL. One of the most pressing indicators of distress is the interest coverage ratio, which stands at -0.192. Interest coverage measures how easily a company can pay the interest on its outstanding debt using its operating earnings. A negative ratio indicates that the company’s current earnings are insufficient to cover even a fraction of its interest obligations, suggesting a heightened risk of financial instability. Because the company is not generating positive earnings, traditional metrics like debt payback years cannot be meaningfully calculated. In an environment of fluctuating interest rates and potential currency instability, a firm that cannot service its debt from operations faces significant headwinds.

Valuation:
The valuation metrics for DHCNL do not provide a traditional "value" signal. The Price-to-Earnings (P/E) ratio is reported at -267.2857. It is important for investors to understand that a negative P/E ratio does not mean a stock is "cheap" in the sense of being undervalued; rather, it simply reflects that the company is not producing positive earnings. Without positive net income, standard valuation multiples lose their predictive power. Investors are essentially looking at a company that is consuming capital rather than producing it, making the assessment of "price versus value" highly speculative until a clear path to profitability is established.

Price Trends and Market Position:
Despite the fundamental weaknesses, the technical indicators provide a conflicting signal. The moving average trend is noted as a "PASS," and the system identifies a "BUY TREND." However, it must be noted that specific chart history, including latest closes and individual moving average values (MA20, MA50, MA200), are currently unavailable in the provided dataset. While the "BUY TREND" signal exists, it stands in stark contrast to the failing fundamental checklist. An investor should view this technical strength with extreme caution, as a positive price trend in the absence of earnings support can often be a temporary market movement rather than a reflection of improved business quality.

The Investment Case:
The case for Diversified Healthcare Trust is currently heavily weighted toward the negative. The favorable evidence is almost exclusively limited to technical trend signals, which may suggest short-term momentum or market positioning. However, the unfavorable evidence is substantial and systemic: negative EPS, a negative ROIC, and an inability to cover interest expenses. For a cautious investor, the lack of earnings growth (scoring only 10/100) and the failure to meet basic profitability checklists suggest that any potential upside is speculative. The primary challenge for the company will be to reverse these operational losses and stabilize its balance sheet before technical trends fade.

Risks and Final Assessment:
The principal risks facing DHCNL are centered on its inability to generate positive cash flow and cover its debt obligations. The combination of negative interest coverage and negative ROIC creates a cycle where the company may have to rely on external financing—often at higher costs in volatile macro environments—to sustain operations. This increases the risk of capital erosion and long-term insolvency. Until the company demonstrates a sustained ability to produce positive earnings and improve its interest coverage, the fundamental outlook remains precarious. A key metric to watch next would be a shift toward positive EPS or an improvement in the interest coverage ratio, which would signal that the company is moving toward operational stability.

Final Verdict: Avoid for Now

This is educational research, not financial advice.

Mac Gemton IV editorial portrait
Mac Gemton IV
Hard Money Risk Analyst · StockValueFinder Editorial Persona

Mac Gemton IV is a financial research analyst specializing in equity valuation, ETF performance, dividend income strategies, and investment risk assessment. With a disciplined, data-driven approach, he examines company fundamentals, earnings growth, balance-sheet strength, valuation ratios, historical returns, and market trends. His research focuses on identifying financial strengths, potential risks, and long-term investment considerations, transforming complex financial data into clear, practical analysis for everyday investors.

This is the latest completed research. Updated reports are prepared in the background.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

30%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
FAIL

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
PASS

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
BUY TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA18.65
50-Day MA18.94
200-Day MA18.30
MA Score4

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top